Efficacy of Ezetimibe is Associated with Gender and Baseline Lipid Levels in Patients with Type 2 Diabetes-Reference-Cited by-同舟云学术

Efficacy of Ezetimibe is Associated with Gender and Baseline Lipid Levels in Patients with Type 2 Diabetes

Published:2012 Issue:9 Volume:19 Page:846-853
ISSN:1340-3478
Container-title:Journal of Atherosclerosis and Thrombosis
language:en
Short-container-title:JAT

Author:

Shigematsu Erina¹,Yamakawa Tadashi¹,Taguri Masataka²,Morita Satoshi²,Tokui Mikiya³,Miyamoto Kazunori³,Funae Osamu³,Takatuka Yoji⁴,Kadonosono Kazuaki⁵,Shigematsu Hiroshi⁶,Terauchi Yasuo⁷

Affiliation:

1. Department of Endocrinology and Diabetes, Yokohama City University Medical Center.

2. Department of Biostatistics and Epidemiology, Yokohama City University Medical Center.

3. Tokui Medical Clinic.

4. Motomachi Takatuka Medical Clinic.

5. Department of Ophthalmology, Yokohama City University Medical Center.

6. Sato Clinic.

7. Department of Endocrinology and Metabolism, Yokohama City University School of Medicine.

Publisher

Japan Atherosclerosis Society

Subject

Biochemistry (medical),Cardiology and Cardiovascular Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/jat/19/9/19_12799/_pdf

Reference31 articles.

1. 1) Teramoto T, Sasaki J, Ueshima H, Egusa G, Kinoshita M, Shimamoto K, et al: Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese. J Atheroscler Thromb, 2007; 14: 45-50

2. 2) Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA, 2001; 285: 2486-2497

3. 3) Haffner SM: Dyslipidemia management in adults with diabetes. Diabetes Care, 2004; 27 Suppl 1: S68-S71

4. 4) Dembowski E, Davidson MH: Statin and ezetimibe combination therapy in cardiovascular disease. Curr Opin Endocrinol Diabetes Obes, 2009; 16: 183-188

5. 5) Davis HR Jr, Compton DS, Hoos L, Tetzloff G: Ezetimibe, a potent cholesterol absorption inhibitor, inhibits the development of atherosclerosis in ApoE knockout mice. Arterioscler Thromb Vasc Biol, 2001; 21: 2032-2038

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Italian Association of Hospital Cardiologists Position Paper ‘Gender discrepancy: time to implement gender-based clinical management’;European Heart Journal Supplements;2024-04

2. Impact of Sex and Gender on Clinical Management of Patients with Advanced Chronic Liver Disease and Type 2 Diabetes;Journal of Personalized Medicine;2023-03-20

3. The effect of switching from statin-monotherapy to statin/ezetimibe combination therapy on lipid profiles in patients with type 2 diabetes and dyslipidemia: a multicenter open-label study (EUCLID);Vascular Failure;2020-12-21

4. Postprandial Hypertriglyceridaemia Revisited in the Era of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement, Narrative Review;Current Vascular Pharmacology;2019-08-01

5. Porównanie wpływu krótkotrwałego leczenia hipolipemicznego na stężenie adipokin w osoczu kobiet i mężczyzn z izolowaną hipercholesterolemią;Endokrynologia Polska;2015-05-01